Publications by authors named "Hande Turna"

Claim this Profile
E
Effects of immune related adverse events and corticosteroids on the outcome of patients treated with immune checkpoint inhibitors.
Gülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, Shamkhal Safarov, Murad Guliyev, Hande Turna

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors.
Gülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, Murad Guliyev, Günay Can, Hande Turna

Clin Transl Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer.
Gülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, Murad Guliyev, Hande Turna

Tumori· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and phenotypic changes in natural killer cells expressing immune checkpoint receptors PD-1, CTLA-4, LAG-3, and TIGIT in non-small cell lung cancer: the comparative analysis of tumor microenvironment, peripheral venous blood, and tumor-draining veins.
Fehim Esen, Duygu Ilke Cikman, Ayse Engin, Akif Turna, Sebnem Batur, Hande Zeynep Turna

Immunol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study.
Nuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, Yuksel Urun, Umut Demirci, Hande Turna

Curr Med Res Opin· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-4 Cycles versus 6 Cycles Neoadjuvant Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: Survival Is Not Determined by the Number of Neoadjuvant Chemotherapy Cycles.
Tugan Bese, Elifnur Bicer, Basak Ozge Kayan, Sait Sukru Cebi, Abdullah Serdar Acikgoz, Hande Turna

Chemotherapy· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study.
Murad Guliyev, Gülin Alkan Şen, İlkay Gültürk, Nargiz Majidova, Goncagül Akdağ, Hande Turna

Breast Cancer Res Treat· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer.
Gülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, Günay Can, Hande Turna

Lung Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation recall myositis with pazopanib in a patient with soft tissue sarcoma.
Melike Pekyürek Varan, Hande Turna, Fazilet Öner Dinçbaş

J Oncol Pharm Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
Gilberto de Castro, Iveta Kudaba, Yi-Long Wu, Gilberto Lopes, Dariusz M Kowalski, Hande Z Turna

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy.
Ezgi Değerli, Nihan Şentürk Öztaş, Gülin Alkan, Şahin Bedir, Sümeyra Derin, Hande Turna

J Chemother· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Levent Emirzeoglu, Serdar Arici, Ahmet Bilgehan Sahin, Birol Ocak, Naziye Ak, Hande Turna

Breast Care (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell carcinoma in Turkey: A multicentric study.
Fatih Yildiz, Umut Demirci, Ahmet Küçükarda, Mahmut Büyüksimsek, Teoman Sakalar, Hande Turna

J Cancer Res Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local aromatase activity alterations in breast cancer tissues: A potential way of decision support for clinicians.
Mete Bora Tuzuner, Tulin Ozturk, Sennur Ilvan, Hande Turna, Turkan Yurdun

Exp Mol Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients.
Nir Peled, Roni Gillis, Saadettin Kilickap, Patrizia Froesch, Sergei Orlov, Hande Turna

Lung Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
H Arzu Yaşar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan

J Oncol Pharm Pract· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study.
Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Hande Turna

BMC Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
Yüksel Ürün, H Arzu Yaşar, Hande Turna, Saadettin Kılıçkap, Ahmet Sezer

J Oncol Pharm Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study.
Yuksel Urun, H Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef

J Oncol Pharm Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna

Lancet· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
Hale Demir, Ozgecan Dulgar, Bugra Taygun Gulle, Hande Turna, Sennur Ilvan

Bosn J Basic Med Sci· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study.
Şuayib Yalçın, Ramazan Yildiz, Faysal Dane, Aziz Karaoğlu, Berna Öksüzoğlu, Hande Turna

Onco Targets Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Hande Turna

Lancet· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases.
Mete Bora Tüzüner, Tülin Öztürk, Allison Pınar Eronat, Fatih Seyhan, Halil İbrahim Kısakesen, Hande Turna

Biochem Genet· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Caseload Volume is Associated With Better Oncologic Outcomes After Laparoscopic Resections for Colorectal Cancer.
Cigdem Benlice, Bilgi Baca, Sadiye Nur Firidin, Aybuke Muti, Erman Aytac, Hande Turna

Surg Laparosc Endosc Percutan Tech· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis